Selecting the right contract development and manufacturing organization starts long before the first site visit or capability presentation. It starts with a well-structured Request for Proposal.
A peptide manufacturing RFP template guide gives biotech and pharmaceutical companies the framework they need to communicate requirements clearly, evaluate responses consistently, and ultimately choose a manufacturing partner that aligns with their quality standards, timelines, and budget constraints.
Too often, organizations rush through the RFP process with vague specifications and incomplete evaluation criteria, leading to mismatched partnerships that cost time and money. This guide walks you through every section your peptide manufacturing RFP should contain, provides practical tips for scoring vendor responses, and offers a downloadable-ready structure you can adapt to your specific program needs.
- A structured RFP eliminates ambiguity and ensures every prospective CDMO responds to the same requirements, enabling fair comparison.
- Technical specifications must be precise, covering peptide length, purity targets, scale requirements, and analytical method expectations.
- Quality and regulatory sections should address current GMP compliance, audit history, and filing support capabilities.
- Pricing structures should be itemized, not lump-sum, so you can compare cost components across vendors.
- Timeline expectations need to include milestones for technology transfer, process validation, and commercial readiness.
- Evaluation criteria and weighting should be defined before RFP distribution to prevent bias during the review process.
- Including a confidentiality framework in the RFP protects proprietary process information and intellectual property from the outset.
What Is a Peptide Manufacturing RFP?
A peptide manufacturing RFP is a formal document issued by a sponsor company to solicit detailed proposals from CDMOs capable of producing peptide-based active pharmaceutical ingredients or drug products. Unlike a simple request for quotation, which focuses primarily on pricing, an RFP encompasses technical capabilities, quality systems, regulatory experience, project management approach, timeline commitments, and commercial terms.
The RFP serves as both a communication tool and an evaluation instrument. It communicates your program's requirements in sufficient detail for vendors to prepare meaningful responses, and it establishes the criteria against which those responses will be judged.
For peptide programs specifically, the RFP must address unique considerations such as solid-phase versus liquid-phase synthesis capabilities, purification methods for complex sequences, and experience with peptide-specific stability and degradation challenges.
Why It Matters
The consequences of a poorly executed CDMO selection are severe and often irreversible in the short term. Switching manufacturing partners mid-program can add six to eighteen months to development timelines and cost hundreds of thousands of dollars in duplicated technology transfer and validation work.
A rigorous RFP process dramatically reduces the risk of selecting a partner whose capabilities, capacity, or quality systems do not match your program's demands.
For peptide manufacturers, the stakes are even higher because peptide synthesis requires specialized expertise that varies significantly from one CDMO to another. A vendor that excels at short-sequence commodity peptides may struggle with long, complex sequences that require advanced purification and formulation capabilities.
The RFP is your primary tool for distinguishing between vendors that can genuinely meet your needs and those that are simply eager for the business.
Beyond risk mitigation, a strong RFP process also accelerates decision-making by providing a structured framework for internal stakeholders to align on priorities and evaluation criteria before reviewing vendor responses.
Benefits Checklist
- Standardized evaluation: Every vendor responds to the same questions, enabling objective comparison across proposals.
- Reduced selection risk: Detailed technical and quality requirements surface capability gaps before contracts are signed.
- Cost transparency: Itemized pricing requests reveal the true cost structure behind each proposal, not just the bottom line.
- Faster internal alignment: A defined evaluation rubric helps cross-functional teams agree on priorities and scoring before vendor reviews begin.
- Stronger negotiations: The depth of information requested in a well-crafted RFP gives your procurement team leverage during contract discussions.
- Regulatory preparedness: Including regulatory expectations in the RFP ensures your CDMO partner is ready for inspection and filing support from day one.
- Intellectual property protection: Embedding confidentiality and IP terms in the RFP establishes legal protections at the earliest stage of engagement.
Services Breakdown
| RFP Section | Purpose | Key Content to Include |
|---|---|---|
| Company Overview Request | Assess organizational stability | Financial health, ownership structure, employee count, facility locations |
| Technical Capabilities | Evaluate manufacturing fit | Synthesis platforms, scale range, purification methods, analytical capabilities |
| Quality Systems | Confirm regulatory readiness | GMP status, audit history, deviation management, CAPA processes |
| Regulatory Experience | Assess filing support | DMF filings, FDA/EMA inspection outcomes, regulatory submission experience |
| Project Management | Understand execution approach | Communication protocols, milestone tracking, escalation procedures |
| Pricing and Commercial Terms | Enable cost comparison | Itemized pricing, payment terms, minimum order quantities, price escalation clauses |
| Timeline and Capacity | Confirm schedule feasibility | Lead times, capacity allocation, scale-up timelines, batch scheduling flexibility |
| References and Case Studies | Validate track record | Similar program examples, client references, success metrics |
Tips for Success
-
Define your requirements before writing the RFP. Assemble your cross-functional team, including representatives from process development, quality, regulatory, supply chain, and finance, and document every requirement before drafting a single RFP section. Internal alignment upfront prevents scope creep later.
-
Be specific about peptide characteristics. Include the target peptide sequence, desired purity levels (typically 95% or higher for clinical material), expected batch sizes, and any known synthesis challenges such as aggregation-prone sequences or difficult couplings. Vague specifications lead to vague proposals.
-
Request itemized pricing with clear assumptions. Ask vendors to break down their quotes into labor, raw materials, facility time, analytical testing, quality oversight, and project management. Require them to state the assumptions underlying each estimate, including batch success rates and raw material costs.
-
Include your evaluation criteria and weighting. Sharing your scoring methodology in the RFP itself signals transparency and encourages vendors to focus their responses on the areas you value most. A typical weighting might allocate 30% to technical capability, 25% to quality systems, 20% to pricing, 15% to timeline, and 10% to references.
-
Set a realistic response timeline. Give vendors at least four to six weeks to prepare a thorough response. Rushed timelines produce incomplete proposals and may cause top-tier CDMOs to decline participation altogether.
-
Build in a Q&A period. Allow a formal question-and-answer window where all prospective bidders can submit clarifying questions and receive anonymized answers distributed to all participants. This ensures fairness and improves the quality of responses.
-
Plan for site visits before final selection. Your RFP should inform vendors that shortlisted candidates will be invited for a site audit. This sets expectations and ensures only serious contenders invest time in detailed proposals.
Comparison Table
| Evaluation Criterion | Weight | What to Assess | Red Flags |
|---|---|---|---|
| Technical Capability | 30% | Synthesis platforms, scale range, analytical suite | No experience with peptides over 30 amino acids |
| Quality Systems | 25% | GMP status, audit outcomes, deviation trends | Recent FDA warning letters or repeated observations |
| Pricing Competitiveness | 20% | Total cost, itemization clarity, escalation terms | Lump-sum pricing with no breakdown provided |
| Timeline Feasibility | 15% | Lead times, capacity availability, milestone plan | Unrealistically short timelines without justification |
| References and Track Record | 10% | Similar programs, client satisfaction, case studies | Inability to provide relevant peptide references |
For a comprehensive framework on evaluating CDMO capabilities beyond the RFP stage, review our guide on CDMO vendor evaluation.
If your team is also evaluating options for outsourcing earlier-stage development work, our resource on peptide process development provides useful context for structuring those engagements.
The International Society for Pharmaceutical Engineering offers in-depth guidance on manufacturing vendor qualification and selection best practices. Their ISPE Good Practice Guide on Technology Transfer is an essential reference for organizations preparing to transition peptide manufacturing processes to a new CDMO partner.
Frequently Asked Questions
What should be included in a peptide manufacturing RFP?
A strong RFP includes sections on technical capabilities, quality systems, regulatory experience, pricing, timeline, and references. For peptide programs specifically, you should also address synthesis platform type, purity targets, and experience with complex or long-chain sequences.
How long should I give vendors to respond to a peptide manufacturing RFP?
Give vendors at least four to six weeks to prepare a thorough response. Shorter timelines lead to incomplete proposals and may cause the most qualified CDMOs to decline the opportunity entirely.
How do I compare CDMO bids fairly after receiving RFP responses?
Define your evaluation criteria and scoring weights before you distribute the RFP. A common approach allocates 30% to technical capability, 25% to quality systems, 20% to pricing, 15% to timeline, and 10% to references.
Why does pricing need to be itemized in a peptide manufacturing RFP?
Itemized pricing breaks down the cost of labor, materials, analytical testing, and quality oversight separately. This makes it possible to compare vendors on an equal footing rather than just comparing a single lump-sum number that may include very different assumptions.
What are the biggest risks of skipping a formal RFP process for CDMO selection?
Skipping the RFP process often leads to mismatched partnerships where vendor capabilities do not match your program needs. Switching CDMOs mid-program can add six to eighteen months to development timelines and hundreds of thousands of dollars in duplicated work.
Topics
Dr. Michael Torres
Healthcare Staffing Consultant
MD, Healthcare Administration | 11 years in clinical staffing
Former physician turned healthcare staffing specialist. Advises peptide clinics and regenerative medicine practices on credentialing, provider placement, and team structure.
Reviewed by Dr. Michael Torres, MD, April 2026